{"SPADE_UN_19665": {"Sequence Information": {"Peptide Name": "", "Sequence": "XXXX", "Sequence Length": 4, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Structure-activity relationships in ultrashort cationic lipopeptides: the effects of amino acid ring constraint on antibacterial activity.", "Pubmed ID": "25069750", "Reference": "Amino Acids. 2014;46:2517-2530", "Author": "Domalaon R, Yang X, O'Neil J, Zhanel GG, Mookherjee N, Schweizer F", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/25069750"}, {"Title": "Ultrashort cationic lipopeptides and lipopeptoids: Evaluation and mechanistic insights against epithelial cancer cells.", "Pubmed ID": "27486068", "Reference": "Peptides. 2016;84:58-67", "Author": "Domalaon R, Findlay B, Ogunsina M, Arthur G, Schweizer F", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/27486068"}], "SPADE ID": "SPADE_UN_19665", "Similar Sequences": [], "Hemolytic Activity": "", "Target Organism": "Staphylococcus aureus ATCC 29213(MIC=64µg/ml),Staphylococcus aureus ATCC 29213(MIC=256µg/ml),Staphylococcus aureus ATCC 33592(MIC=64µg/ml),Staphylococcus aureus ATCC 33592(MIC=512µg/ml),Escherichia coli ATCC 25922(MIC=128µg/ml),Escherichia coli ATCC 25922(MIC=512µg/ml),Pseudomonas aeruginosa ATCC 27853(MIC=256µg/ml),Pseudomonas aeruginosa ATCC 27853(MIC=>512µg/ml),Human acute monocytic leukemia THP-1(40-50% Cytotoxicity=80µM),Human breast adenocarcinoma MDA-MB-231(50% Cell death=>30µM),Human prostate cancer DU145(50% Cell death=>30µM),Human pancreatic carcinoma Mia PaCa-2(50% Cell death=>30µM)"}}}